Wuhan Jianmin Pharmaceutical Group Co., Ltd. (600976) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Wuhan Jianmin Pharmaceutical Group Co., Ltd. Company Snapshot

Business Description:

Wuhan Jianmin Pharmaceutical Group Co., Ltd. operates in the Pharmaceutical preparations sector. Wuhan Jianmin Pharmaceutical Groups Co. Ltd is a China-based company primarily engaged in manufacture and distribution of pharmaceuticals. The Company provides granules, tablets and pills, among others, such as granule drugs for the prevention and cure of child calcium deficiency, tablet drugs for the treatment of faucitis and throat protection, as well as drugs for enhancing blood generation. The Company also involves in operation of drug stores. During the year ended December 31, 2010, the Company obtained approximately 70.79% of its total revenue from pharmaceutical commerce. The Company operates its businesses principally in domestic markets. In our complete report available for purchase the company is compared to: Tong Ren Tang Technologies Company Limited, Zhejiang Xianju Pharmaceutical Co Limited and Guangxi Wuzhou Zhongheng Group, Ltd..

Wuhan Jianmin Pharmaceutical Group Co., Ltd.

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 14.40
(Figures in Chinese Renmimbi)

1 Week	n/a	13 Weeks	6.3%

4 Weeks	-9.2%	52 Weeks	-31.7%

Wuhan Jianmin Pharmaceutical Group Co., Ltd. Key Data:

Ticker:	600976	Country:	CHINA

Exchanges:	SHG	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	1,571,985,000 (Year Ending Jan 2011).	Employees:	808

Currency:	Chinese Renmimbi	Market Cap:	2,208,939,840

Fiscal Yr Ends:	December	Shares Outstanding:	153,398,600

Share Type:	A Gu	Closely Held Shares:	N/A

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.